Search research articles
Contact Us
Filters
Showing results (151-160 of 314) with videos related to
Page
of 32
Sort By:
The Journal of Clinical Investigation
|
January 17, 2023
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
Víctor A Arrieta, Crismita Dmello, Daniel J McGrail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2004
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide
Monika E Hegi, Annie-Claire Diserens, Sophie Godard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2008
Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor
John O Prior, Michael Montemurro, Maria-Victoria Orcurto, et al.
Bioelectrochemistry (Amsterdam, Netherlands)
|
October 28, 2022
Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy
Christoph Pohling, Ha Nguyen, Edwin Chang, et al.
Oncogene
|
April 3, 2020
Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth
Rexhep Uka, Christian Britschgi, Anja Krättli, et al.
Neuro-Oncology Advances
|
January 7, 2022
Ultrasound-mediated blood-brain barrier opening increases cell-free DNA in a time-dependent manner
Daniel Y Zhang, Andrew Gould, Hannah C Happ, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 10, 2010
Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning
Elena Musat, Erik Roelofs, Raquel Bar-Deroma, et al.
The Lancet. Oncology
|
August 11, 2012
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
Annika Malmström, Bjørn Henning Grønberg, Christine Marosi, et al.
BMC Cancer
|
January 13, 2018
Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study
Alexander R Siebenhüner, Heike Seifert, Helga Bachmann, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 25, 2008
Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes
Karin Ribi, Jürg Bernhard, Jan C Schuller, et al.
Page
of 32
Search research articles
Search
Showing results (151-160 of 314) with videos related to
Sort By:
Page
of 32
The Journal of Clinical Investigation
|
January 17, 2023
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
Víctor A Arrieta, Crismita Dmello, Daniel J McGrail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2004
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide
Monika E Hegi, Annie-Claire Diserens, Sophie Godard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2008
Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor
John O Prior, Michael Montemurro, Maria-Victoria Orcurto, et al.
Bioelectrochemistry (Amsterdam, Netherlands)
|
October 28, 2022
Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy
Christoph Pohling, Ha Nguyen, Edwin Chang, et al.
Oncogene
|
April 3, 2020
Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth
Rexhep Uka, Christian Britschgi, Anja Krättli, et al.
Neuro-Oncology Advances
|
January 7, 2022
Ultrasound-mediated blood-brain barrier opening increases cell-free DNA in a time-dependent manner
Daniel Y Zhang, Andrew Gould, Hannah C Happ, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 10, 2010
Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning
Elena Musat, Erik Roelofs, Raquel Bar-Deroma, et al.
The Lancet. Oncology
|
August 11, 2012
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
Annika Malmström, Bjørn Henning Grønberg, Christine Marosi, et al.
BMC Cancer
|
January 13, 2018
Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study
Alexander R Siebenhüner, Heike Seifert, Helga Bachmann, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 25, 2008
Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes
Karin Ribi, Jürg Bernhard, Jan C Schuller, et al.
Page
of 32